Paper Details

  1. Home
  2. Paper Details

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.

Author: Angeles-HanSheila T, Barbar-SmileyFatima, BeckerMara L, CooperAshley M, CronRandy Q, CuelloCarlos A, EdelheitBarbara, FeldmanBrian M, FergusonPolly J, FlanaganElaine, GewanterHarry, Gillispie-TaylorMiriah, GuzmanJaime, HaysKimberly, HortonDaniel B, KimuraYukiko, Klein-GitelmanMarisa, LeeTzielan, LovellDaniel J, MannionMelissa L, MurphyKatherine, NigrovicPeter A, OmbrelloMichael J, OnelKaren B, PetersonRosemary, RabinovichC Egla, RestonJames T, SaadNadine, ShenoiSusan, SullivanNancy, SzymanskiAnn Marie, TesherMelissa, TrachtmanRebecca, TurgunbaevMarat, TurnerAmy S, TwiltMarinka, VeigaKeila

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, N.I.H., IntramuralFunding provided by the NIH for research projects within the NIH.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This clinical practice guideline provides recommendations for the management of juvenile idiopathic arthritis (JIA), including nonpharmacologic therapies, medication monitoring, immunizations, and imaging.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To provide recommendations for the management of juvenile idiopathic arthritis (JIA) with a focus on nonpharmacologic therapies, medication monitoring, immunizations, and imaging, irrespective of JIA phenotype. METHODS: We developed clinically relevant Patient/Population, Intervention, C...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/35233989

データ提供：米国国立医学図書館（NLM）

Guiding the Management of Juvenile Idiopathic Arthritis: A Comprehensive Guideline

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease affecting children and adolescents. This guideline provides recommendations for the management of JIA, focusing on nonpharmacologic therapies, medication monitoring, immunizations, and imaging. The guideline was developed through a rigorous process involving a systematic literature review, grading of recommendations, and consensus among clinicians and patients/caregivers. The goal is to provide evidence-based recommendations to support clinicians in making informed decisions regarding the management of JIA.

A Holistic Approach to JIA Management

The guideline emphasizes a holistic approach to JIA management, encompassing nonpharmacologic therapies such as physical therapy, occupational therapy, and a healthy diet. It also provides recommendations for laboratory monitoring of medications, the importance of immunizations, and the use of imaging techniques. By integrating these various aspects of care, the guideline aims to promote optimal outcomes for children and adolescents with JIA. The guideline underscores the importance of shared decision-making with patients/caregivers, ensuring that treatment plans are tailored to individual needs and preferences.

Navigating the Challenges of JIA: A Dr. Camel's Perspective

Imagine a young desert gazelle struggling to navigate a treacherous landscape. JIA, like a sudden sandstorm, can disrupt the gazelle's ability to move freely and experience life fully. This guideline, like a knowledgeable guide, provides tools and strategies to help the gazelle navigate the challenges of JIA, promoting its well-being and allowing it to continue exploring its world.

Dr. Camel's Conclusion

This guideline serves as a valuable resource for clinicians, patients, and caregivers involved in the management of JIA. It provides evidence-based recommendations for a comprehensive approach to care, encompassing nonpharmacologic therapies, medication monitoring, immunizations, and imaging. The guideline promotes shared decision-making, ensuring that treatment plans are individualized and tailored to meet the unique needs and preferences of each patient.

Date :
  1. Date Completed 2022-05-04
  2. Date Revised 2023-06-01
Further Info :

Pubmed ID

35233989

DOI: Digital Object Identifier

NIHMS1766740

Related Literature

Article Analysis
・Effective treatment of arthritis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.